Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Bipolar relapse risk around childbirth

Psychiatry · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Emerging mania, psychosis or dangerous depression

A new marked reduction in need for sleep, escalating energy, disinhibition, racing thoughts, psychotic beliefs, severe agitation, suicidal intent or inability to care safely for self or baby may represent a rapidly evolving bipolar episode and cannot wait for a routine postnatal appointment.

Action: Keep the parent and baby safe with continuous responsible support, assess immediate physical and obstetric causes and access to means, contact the specialist perinatal or crisis service urgently, and arrange same-day emergency assessment; suspected postpartum psychosis requires immediate specialist assessment, with NICE specifying assessment within four hours of referral.

Synopsis

Prevent and detect bipolar relapse across pregnancy, birth and the early postnatal transition by combining an individual episode history, carefully planned prophylaxis, sleep protection, rapid specialist access and a written response to early warning signs.

  • Bipolar disorder has a heightened risk of relapse and first presentation after birth; prevention begins during preconception or antenatal care rather than after symptoms become unmistakable.
  • Map previous mania, depression, mixed states, psychosis, admissions, postpartum episodes, time to deterioration after stopping treatment and the earliest signs recognised by the person or family.
  • Do not reduce relapse planning to a drug choice: sleep disruption, feeding arrangements, analgesia, social support, obstetric complications and service handovers can determine whether protection works.
  • If lithium is continued in pregnancy, NICE requires specialist counselling and increasingly frequent plasma monitoring, including weekly levels from 36 weeks, plus hydration and hospital-birth planning.
  • NICE recommends stopping lithium during labour and checking the plasma level 12 hours after the last dose; prescribing ownership and restart timing must be agreed before labour begins.
  • When lithium is stopped in pregnancy or breastfeeding is planned, NICE advises offering antipsychotic prophylaxis after an individual specialist discussion.
  • Protect a consolidated sleep period after birth while respecting feeding preferences; another adult can assist with settling, expressed milk or formula when chosen, and early-morning care.
  • A written plan should name symptoms that trigger same-day contact, the urgent team and telephone number, medicine actions, baby supervision and the threshold for mother and baby unit assessment.
  • Review frequently in the first postnatal weeks and after any sleep collapse, missed medication, physical illness, feeding change or family concern, because deterioration may accelerate over hours or days.

Key red flags

Complete or near-complete loss of sleep without fatigue, increasingly pressured speech, grandiosity or unusual goal-directed activity may precede dangerous postnatal mania.

Delusions involving the baby, command hallucinations, severe confusion, disorganisation or rapidly fluctuating affect requires emergency containment and assessment for psychiatric and physical causes.

Mixed activation with despair, agitation, impulsivity or suicidal thinking can carry high risk even when the person does not appear slowed or conventionally depressed.

Abrupt cessation of lithium or another effective prophylactic medicine, particularly near delivery, should trigger rapid prescriber review because withdrawal and untreated illness both alter relapse risk.

Dehydration, vomiting, pre-eclampsia, renal impairment or interacting medicines in a person taking lithium may produce toxicity and requires an urgent plasma level and medical assessment.

Investigation priorities

01
Longitudinal episode and treatment historyFirst step

Define episode polarity, severity, postpartum timing, previous response and relapse after withdrawal.

Management branches

Antenatal preventionConvert history into a relapse plan

A pregnant person has bipolar disorder, previous postpartum psychosis or another strong bipolar relapse history.

  1. Refer to specialist perinatal mental health care and verify diagnosis, episode pattern, previous effective treatments and consequences of discontinuation.
  2. Agree prophylaxis through an informed comparison of illness, fetal, neonatal and feeding considerations, avoiding abrupt or unsupported medicine changes.
  3. Record early signs, contact frequency, sleep and feeding contingencies, labour medicine instructions and the named postnatal prescriber in a shared plan.

Key medicines

Lithium specialist perinatal protocolDose orally to the individual's correctly timed plasma target; NICE bipolar guidance usually aims for 0.6 to 0.8 mmol/L at first prescribing and considers 0.8 to 1.0 mmol/L for previous relapse on lithium or persistent subthreshold impairment, with perinatal specialist adjustment.Use specialist prescribing, renal and thyroid monitoring, interaction review and frequent pregnancy levels; dehydration, NSAIDs, ACE inhibitors and some diuretics can raise concentrations. NICE advises stopping during labour and avoiding breastfeeding, while exceptional breastfeeding use described by SPS requires expert maternal and infant surveillance.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG192 perinatal recommendationsBipolar prophylaxis, lithium decisions, pregnancy monitoring, labour management and emergency perinatal assessment.
  • NICE CG185 bipolar recommendationsAdult bipolar assessment, lithium targets, monitoring and relapse-prevention principles.
  • SPS bipolar treatment during breastfeedingSpecialist risk assessment and maternal or infant monitoring when lithium or valproate is considered during breastfeeding.
  • RCPsych postpartum psychosisRecognition, risk factors, emergency care, mother and baby unit treatment and recovery planning.
  • NHS England perinatal mental healthCurrent specialist service scope, maternal mental health services and family or parent-infant focus.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom